Between Botox and Juvederm, the pharma pioneers at Allergan have virtually defined the world of nonsurgical aesthetic treatments. Now the company is looking to score a three-peat with Kybella, the only FDA-approved injection for “submental fullness”—better known as the dreaded double chin. But just how does Kybella work? And can it really zap stubborn fat cells?